Diurnal Intraocular Pressure Efficacy of the Timolol-Brimonidine Fixed Combination and the Timolol-Dorzolamide Fixed Combination as a First Choice Therapy in Patients with Pseudoexfoliation Glaucoma

YÜKSEL, NURŞEN; Gok, Mustafa; Altintas, Ozgul; Caglar, Yusuf

doi:10.3109/02713683.2011.584651

Diurnal Intraocular Pressure Efficacy of the Timolol-Brimonidine Fixed Combination and the Timolol-Dorzolamide Fixed Combination as a First Choice Therapy in Patients with Pseudoexfoliation Glaucoma

YÜKSEL N., Gok M., Altintas O., Caglar Y.

CURRENT EYE RESEARCH, cilt.36, sa.9, ss.804-808, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 9
Basım Tarihi: 2011
Doi Numarası: 10.3109/02713683.2011.584651
Dergi Adı: CURRENT EYE RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.804-808
Kocaeli Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the 6-month daytime efficacy of a fixed combination of timolol and brimonidine (BTFC) versus a timolol and dorzolamide fixed combination (DTFC) as a first choice therapy in patients with pseudoexfoliation glaucoma (PXG).